Menu Search
Equities

ICON PLC

IJF:HAN

ICON PLC

Actions
  • Price (EUR)198.75
  • Today's Change-2.75 / -1.36%
  • Shares traded--
  • 1 Year change-15.06%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 16:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

  • Revenue in USD (TTM)8.31bn
  • Net income in USD747.89m
  • Incorporated1989
  • Employees42.25k
  • Location
    ICON PLCSouth County Business ParkLEOPARDSTOWN, Dublin 18DUBLIN 00000IrelandIRL
  • Phone+353 12912000
  • Fax+353 12912700
  • Websitehttps://www.iconplc.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.